Calvin Joel Gordon

9PUBLICATIONS
40CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMedical molecular engineering of nucleic acids and proteinsReproductionMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 17, 2026
The nucleoside analog CMX521 inhibits coronavirus RNA-dependent RNA polymerase via a two-pronged mechanism.

|Jun 05, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

|Mar 14, 2026
Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutation.

Calvin J Gordon, Mizar F Oliva, Hery W Lee

|Feb 27, 2026
1'- and 4'-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases.

Simon M Walker, Calvin J Gordon, Egor P Tchesnokov

|Nov 24, 2025
Structural basis for selective remdesivir incorporation by SARS-CoV-2 polymerase, and S759A resistance.

Kalyan Das, Calvin Gordon, Mizar Oliva

|Jun 04, 2025
Single-Molecule Assay Reveals Binding Dynamics of SARS-CoV-2 Polymerase Components and Provides a New Tool to Distinguish Polymerase Inhibitors.

Terri C Lovell, Heidi A F Dewling, Cynthia Li

Pageof 2

Frequent Collaborators

6 joint publications

Matthias Gotte

4 joint publications

Egor P Tchesnokov

3 joint publications

Hery W Lee

2 joint publications

Kalyan Das